Dr Linda Mileshkin

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

M02 - Mallet Street Campus
The University of Sydney
NSW 2006 Australia

T: 03 9656 1697

Current national competitive grants*


PORTEC-3 - the role of adjuvant chemotherapy in high-risk endometrial cancer
Mileshkin L, Khaw P, Stockler M, Brand A, Martyn J, Sjoquist K, Creutzberg C, Quinn M
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($300,878 over 3 years)

* Grants administered through the University of Sydney